Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis.

Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis.
复制标题

DOI:
10.1186/s12916-021-01948-z
复制
发表时间:
2021-03-09
期刊:
影响因子:
9.3
通讯作者:
Arinaminpathy N
Arinaminpathy N
中科院分区:
医学1区
文献类型:
--
作者:
Ricks S;Kendall EA;Dowdy DW;Sacks JA;Schumacher SG;Arinaminpathy N

文献摘要

参考文献

被引文献

相似文献

检测在应对COVID-19大流行的治疗和预防中发挥着关键作用。与核酸检测(NAT)相比,抗原检测快速诊断检测(Ag-RDTs)更容易获得,但通常具有较低的灵敏度和特异性。通过量化这些权衡,我们旨在为Ag-RDT何时能提供比依赖NAT更大的公共卫生价值的决策提供信息。在专家咨询后,我们选择了两个用例进行分析:在“医院”环境中迅速识别因呼吸道症状入院的患者中的COVID-19感染者,并及早识别和隔离症状轻微的COVID-19感染者-19在“社区”里使用决策分析,我们评估了卫生系统的成本和健康的影响(避免死亡和隔离感染天)的Ag-RDT主导的战略,相比NAT和临床判断的基础上的战略。我们采用了广泛的价值观的“上下文”参数相关的一系列设置,包括NAT的可用性和临床判断的性能。我们对所有这些参数进行了多变量敏感性分析。在医院环境中,当临床判断的灵敏度低于90%时,Ag-RDT主导的策略将避免比基于NAT的策略更多的死亡,并且避免的每例死亡的成本更低,并且当NAT结果及时提供给少于85%的患者的临床决策时。Ag-RDT的使用在社区环境中得到了强有力的支持,在广泛的假设下,它将以比单独依赖NAT更低的成本避免更多的传输。尽管其灵敏度和特异性不完美,但Ag-RDT有可能同时更具影响力,并且比目前的COVID-19诊断检测方法具有更低的每例死亡和避免感染人日成本。在线版本包含补充材料,可通过10.1186/s12916-021-01948-z获得。
Testing plays a critical role in treatment and prevention responses to the COVID-19 pandemic. Compared to nucleic acid tests (NATs), antigen-detection rapid diagnostic tests (Ag-RDTs) can be more accessible, but typically have lower sensitivity and specificity. By quantifying these trade-offs, we aimed to inform decisions about when an Ag-RDT would offer greater public health value than reliance on NAT. Following an expert consultation, we selected two use cases for analysis: rapid identification of people with COVID-19 amongst patients admitted with respiratory symptoms in a ‘hospital’ setting and early identification and isolation of people with mildly symptomatic COVID-19 in a ‘community’ setting. Using decision analysis, we evaluated the health system cost and health impact (deaths averted and infectious days isolated) of an Ag-RDT-led strategy, compared to a strategy based on NAT and clinical judgement. We adopted a broad range of values for ‘contextual’ parameters relevant to a range of settings, including the availability of NAT and the performance of clinical judgement. We performed a multivariate sensitivity analysis to all of these parameters. In a hospital setting, an Ag-RDT-led strategy would avert more deaths than a NAT-based strategy, and at lower cost per death averted, when the sensitivity of clinical judgement is less than 90%, and when NAT results are available in time to inform clinical decision-making for less than 85% of patients. The use of an Ag-RDT is robustly supported in community settings, where it would avert more transmission at lower cost than relying on NAT alone, under a wide range of assumptions. Despite their imperfect sensitivity and specificity, Ag-RDTs have the potential to be simultaneously more impactful, and have a lower cost per death and infectious person-days averted, than current approaches to COVID-19 diagnostic testing. The online version contains supplementary material available at 10.1186/s12916-021-01948-z.
DOI: 10.15585/mmwr.mm6915e3
发表时间: 2020-04-17
期刊: MMWR. Morbidity and mortality weekly report
影响因子: --
作者:
Garg S;Kim L;Whitaker M;O'Halloran A;Cummings C;Holstein R;Prill M;Chai SJ;Kirley PD;Alden NB;Kawasaki B;Yousey-Hindes K;Niccolai L;Anderson EJ;Openo KP;Weigel A;Monroe ML;Ryan P;Henderson J;Kim S;Como-Sabetti K;Lynfield R;Sosin D;Torres S;Muse A;Bennett NM;Billing L;Sutton M;West N;Schaffner W;Talbot HK;Aquino C;George A;Budd A;Brammer L;Langley G;Hall AJ;Fry A
通讯作者: Fry A
在感染期间,什么时候可以检测到SARS-COV-2,并且不再使用基于RT-PCR的测试检测到?对个别参与者数据的系统审查。
DOI: 10.1186/s12916-020-01810-8
发表时间: 2020-11-04
期刊: BMC medicine
影响因子: 9.3
作者:
Mallett S;Allen AJ;Graziadio S;Taylor SA;Sakai NS;Green K;Suklan J;Hyde C;Shinkins B;Zhelev Z;Peters J;Turner PJ;Roberts NW;di Ruffano LF;Wolff R;Whiting P;Winter A;Bhatnagar G;Nicholson BD;Halligan S
通讯作者: Halligan S
DOI: 10.1111/joim.13089
发表时间: 2020-06-17
影响因子: 11.1
作者:
Lechien, Jerome R.;Chiesa-Estomba, Carlos M.;Saussez, Sven
通讯作者: Saussez, Sven
DOI: 10.1038/s41591-020-0869-5
发表时间: 2020-04-15
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
He, Xi;Lau, Eric H. Y.;Leung, Gabriel M.
通讯作者: Leung, Gabriel M.
DOI: 10.1371/journal.pone.0242958
发表时间: 2020
期刊: PloS one
影响因子: 3.7
作者:
Arevalo-Rodriguez I;Buitrago-Garcia D;Simancas-Racines D;Zambrano-Achig P;Del Campo R;Ciapponi A;Sued O;Martinez-García L;Rutjes AW;Low N;Bossuyt PM;Perez-Molina JA;Zamora J
通讯作者: Zamora J